|
|
| (8 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|X}} |
| | *'''[[Diagnosis (Laboratory other parameters)]]''' | | *'''[[Diagnosis (Laboratory other parameters)]]''' |
| | + | *'''[[Dx multi-virus]]''' |
| | *'''[[Dx PCR]]''' | | *'''[[Dx PCR]]''' |
| | *'''[[Dx Antigen]]''' | | *'''[[Dx Antigen]]''' |
| Zeile 10: |
Zeile 12: |
| | | | |
| | ---- | | ---- |
| − | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
| |
| − | {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
| |
| − | {{tp|p=32156101|t=2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| |
| − | {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
| |
| − | {{tp|p=32403009|t=2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet |pdf=|usr=}}
| |
| − | {{tp|p=32372836|t=2020. The problems with so-called immunity tests |pdf=|usr=}}
| |
| − | {{tp|p=32475012|t=2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.|pdf=|usr=007}}
| |
| − | {{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32469511|t=2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?|pdf=|usr=008}}
| |
| − | {{tp|p=32395391|t=2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.|pdf=|usr=008}}
| |
| − | {{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
| |
| − | {{tp|p=32452225|t=2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.|pdf=|usr=008}}
| |
| − | {{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
| |
| − | {{tp|p=32473233|t=2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.|pdf=|usr=008}}
| |
| − | {{tp|p=32496708|t=2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?|pdf=|usr=008}}
| |
| − |
| |
| − | ===009===
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32434518|t=2020. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.|pdf=|usr=009}}
| |
| − | {{tp|p=32383793|t=2020. Lung Ultrasound and the COVID-19 "Pattern": Not All That Glitters Today Is Gold Tomorrow.|pdf=|usr=009}}
| |
| − | {{tp|p=32383781|t=2020. On Lung Ultrasound Patterns Specificity in the Management of COVID-19 Patients.|pdf=|usr=009}}
| |
| − | {{tp|p=32395910|t=2020. Contrast-Enhanced Ultrasound in Patients With COVID-19: Pneumonia, Acute Respiratory Distress Syndrome, or Something Else?|pdf=|usr=009}}
| |
| − | {{tp|p=32227492|t=2020. Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method.|pdf=|usr=009}}
| |
| − | {{tp|p=32513550|t=2020. Diagnosis of Asymptomatic COVID-19 Infection in a Patient Referred for CT Lung Biopsy.|pdf=|usr=009}}
| |
| − | {{tp|p=32445875|t=2020. Ion torrent-based nasopharyngeal swab metatranscriptomics in COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32421144|t=2020. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.|pdf=|usr=009}}
| |
| − | {{tp|p=32310815|t=2020. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples.|pdf=|usr=009}}
| |
| − | {{tp|p=32533391|t=2020. Study on the dynamic change law and correlation between CT imaging manifestations and cellular immunity of 2019 novel coronavirus disease.|pdf=|usr=009}}
| |
| − | {{tp|p=32529815|t=2020. Assessment of the Severity of Coronavirus Disease: Quantitative Computed Tomography Parameters versus Semiquantitative Visual Score.|pdf=|usr=009}}
| |
| − | {{tp|p=32410416|t=2020. Rapidly Progressive COVID-19 Pneumonia: What Radiologists Should Do.|pdf=|usr=009}}
| |
| − | {{tp|p=32410413|t=2020. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.|pdf=|usr=009}}
| |
| − | {{tp|p=32410412|t=2020. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia.|pdf=|usr=009}}
| |
| − | {{tp|p=32524793|t=2020. COVID-19 Carrier or Pneumonia: Positive Real-Time Reverse-Transcriptase Polymerase Chain Reaction but Negative or Positive Chest CT Results.|pdf=|usr=009}}
| |
| − | {{tp|p=32524792|t=2020. Early CT Findings of Coronavirus Disease 2019 (COVID-19) in Asymptomatic Children: A Single-Center Experience.|pdf=|usr=009}}
| |
| − | {{tp|p=32524786|t=2020. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32373786|t=2020. Cautions about radiologic diagnosis of COVID-19 infection driven by artificial intelligence.|pdf=|usr=009}}
| |
| − | {{tp|p=32473662|t=2020. Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.|pdf=|usr=009}}
| |
| − | {{tp|p=32445709|t=2020. RT-PCR for SARS-CoV-2: quantitative versus qualitative.|pdf=|usr=009}}
| |
| − | {{tp|p=32422197|t=2020. Who is most likely to be infected with SARS-CoV-2?|pdf=|usr=009}}
| |
| − | {{tp|p=32311327|t=2020. Rural areas at risk during COVID-19 pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32445713|t=2020. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.|pdf=|usr=009}}
| |
| − | {{tp|p=32479792|t=2020. Testing for COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32437649|t=2020. Challenges in the interpretation and application of typical imaging features of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32526509|t=2020. Could MEFV mutation carriage status have a protective role for COVID-19 pandemic?|pdf=|usr=009}}
| |
| − | {{tp|p=32425648|t=2020. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients.|pdf=|usr=009}}
| |
| − | {{tp|p=32425334|t=2020. Sequence mismatch in PCR probes may mask the COVID-19 detection in Nepal.|pdf=|usr=009}}
| |
| − | {{tp|p=32529418|t=2020. The Potential Role of Smartphone-Based Microfluidic Systems for Rapid Detection of COVID-19 Using Saliva Specimen.|pdf=|usr=009}}
| |
| − | {{tp|p=32379456|t=2020. Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection.|pdf=|usr=009}}
| |
| − | {{tp|p=32376571|t=2020. [Effect of heat inactivation of blood samples on the efficacy of three detection methods of SARS-CoV-2 antibodies].|pdf=|usr=009}}
| |
| − | {{tp|p=32518804|t=2020. Correlation Between Chest CT Findings and Clinical Features of 211 COVID-19 Suspected Patients in Wuhan, China.|pdf=|usr=009}}
| |
| − | {{tp|p=32410825|t=2020. How to increase the SARS-CoV-2 detection rate through the nasopharyngeal swab?|pdf=|usr=009}}
| |
| − | {{tp|p=32528619|t=2020. Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer.|pdf=|usr=009}}
| |
| − | {{tp|p=32450346|t=2020. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.|pdf=|usr=009}}
| |
| − | {{tp|p=32530929|t=2020. Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification.|pdf=|usr=009}}
| |
| − | {{tp|p=32504802|t=2020. Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.|pdf=|usr=009}}
| |
| − | {{tp|p=32411942|t=2020. Covid-19: round and oval areas of ground-glass opacity.|pdf=|usr=009}}
| |
| − | {{tp|p=32407516|t=2020. Response to letter to the editor: "Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction".|pdf=|usr=009}}
| |
| − | {{tp|p=32407487|t=2020. Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction.|pdf=|usr=009}}
| |
| − | {{tp|p=32489938|t=2020. Radiological follow-up of twelve COVID-19 patients with initially normal chest CT.|pdf=|usr=009}}
| |
| − | {{tp|p=32489937|t=2020. Should computed tomography (CT) be used as a screening or follow-up tool for asymptomatic patients with SARS-CoV-2 infection?|pdf=|usr=009}}
| |
| − | {{tp|p=32489936|t=2020. Computed tomography (CT) intestinal alterations of Coronavirus Disease 2019 (COVID-19) from the imaging perspective: a case description.|pdf=|usr=009}}
| |
| − | {{tp|p=32489931|t=2020. Early minimal lesions of COVID-19 pneumonia with interstitial lung abnormality: a case description.|pdf=|usr=009}}
| |
| − | {{tp|p=32489929|t=2020. A systematic review of chest imaging findings in COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32410816|t=2020. A case series of chest imaging manifestation of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32423842|t=2020. False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings.|pdf=|usr=009}}
| |
| − | {{tp|p=32406420|t=2020. High-resolution CT features of the COVID-19 infection in Nanchong City: Initial and follow-up changes among different clinical types.|pdf=|usr=009}}
| |
| − | {{tp|p=32399481|t=2020. Computed tomography findings in a case of coronavirus disease 2019.|pdf=|usr=009}}
| |
| − | {{tp|p=32519256|t=2020. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome.|pdf=|usr=009}}
| |
| − | {{tp|p=32500510|t=2020. Radiological management of COVID-19: structure your diagnostic path to guarantee a safe path.|pdf=|usr=009}}
| |
| − | {{tp|p=32500509|t=2020. Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists.|pdf=|usr=009}}
| |
| − | {{tp|p=32515676|t=2020. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.|pdf=|usr=009}}
| |
| − | {{tp|p=32216718|t=2020. Chest Radiograph Findings in Asymptomatic and Minimally Symptomatic Quarantined Patients in Codogno, Italy during COVID-19 Pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32447034|t=2020. The simulation-CT: Radiotherapy's useful tool in the race against COVID-19 pandemic. A serendipity approach.|pdf=|usr=009}}
| |
| − | {{tp|p=32469732|t=2020. Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals.|pdf=|usr=009}}
| |
| − | {{tp|p=32527255|t=2020. Predictors of fatality including radiographic findings in adults with COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32406576|t=2020. Serum amyloid A is a predictor for prognosis of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32520136|t=2020. COVID-19: the virus in the control of culture?|pdf=|usr=009}}
| |
| − | {{tp|p=32520135|t=2020. A brief history of medical uniforms: from ancient history to the COVID-19 time.|pdf=|usr=009}}
| |
| − | {{tp|p=32419706|t=2020. Guia basica ecografia pulmonar y COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32426303|t=2020. DIAGNOSTICO DE NEUMONIA COVID 19 EN PACIENTES ASINTOMATICOS TRAS LA REALIZACION DE UN PET-TC ONCOLOGICO.|pdf=|usr=009}}
| |
| − | {{tp|p=32449374|t=2020. Laboratory findings of COVID-19: a systematic review and meta-analysis.|pdf=|usr=009}}
| |
| − | {{tp|p=32347067|t=2020. [Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].|pdf=|usr=009}}
| |
| − | {{tp|p=32395897|t=2020. Recent progress on the diagnosis of 2019 Novel Coronavirus.|pdf=|usr=009}}
| |
| − | {{tp|p=32534208|t=2020. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.|pdf=|usr=009}}
| |
| − | {{tp|p=32419875|t=2020. Antikorpertests bei COVID-19 - Was uns die Ergebnisse sagen.|pdf=|usr=009}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32589164|t=2020. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019.|pdf=|usr=010}}
| |
| − | {{tp|p=32562554|t=2020. The role of peripheral blood eosinophil counts in COVID-19 patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32565235|t=2020. Lung ultrasound as an extension of medical examination for COVID-19 pneumonia: much more than an imaging technique.|pdf=|usr=010}}
| |
| − | {{tp|p=32564467|t=2020. Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity.|pdf=|usr=010}}
| |
| − | {{tp|p=32573254|t=2020. Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience.|pdf=|usr=010}}
| |
| − | {{tp|p=32576224|t=2020. CT findings of patients infected with SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32539692|t=2020. Imaging features of the initial chest thin-section CT scans from 110 patients after admission with suspected or confirmed diagnosis of COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32592709|t=2020. Chest CT imaging signature of COVID-19 infection: in pursuit of the scientific evidence.|pdf=|usr=010}}
| |
| − | {{tp|p=32569635|t=2020. Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens among Adult Inpatients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32543160|t=2020. Thoracic Computed Tomography Features of Coronavirus Disease 2019 Patients with Emphysema.|pdf=|usr=010}}
| |
| − | {{tp|p=32592724|t=2020. Room-temperature-storable PCR Mixes for SARS-CoV-2 Detection.|pdf=|usr=010}}
| |
| − | {{tp|p=32569631|t=2020. Impact of Heat-Inactivation on the detection of SARS-CoV-2 IgM and IgG Antibody by ELISA.|pdf=|usr=010}}
| |
| − | {{tp|p=32585417|t=2020. Bringing radiology to patient's home using mobile equipment: A weapon to fight COVID-19 pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32585353|t=2020. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection.|pdf=|usr=010}}
| |
| − | {{tp|p=32558722|t=2020. Incidental Finding of COVID-19 Lung Infection in 18F-FDG PET/CT: What Should We Do?|pdf=|usr=010}}
| |
| − | {{tp|p=32578826|t=2020. Imaging findings in COVID-19 pneumonia.|pdf=|usr=010}}
| |
| − | {{tp|p=32576222|t=2020. VEGF-D: a novel biomarker for detection of COVID-19 progression.|pdf=|usr=010}}
| |
| − | {{tp|p=32560707|t=2020. Screening for low testosterone is needed for early identification and treatment of men at high risk of mortality from Covid-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32576508|t=2020. COVID-19 paraclinical diagnostic tools: Updates and future trends.|pdf=|usr=010}}
| |
| − | {{tp|p=32542842|t=2020. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.|pdf=|usr=010}}
| |
| − | {{tp|p=32592840|t=2020. COVID 19 and low-glucose levels : is there a link ?|pdf=|usr=010}}
| |
| − | {{tp|p=32558646|t=2020. COVID-19 S: A new proposal for diagnosis and structured reporting of COVID-19 on computed tomography imaging.|pdf=|usr=010}}
| |
| − | {{tp|p=32558645|t=2020. CT imaging features of COVID-19 pneumonia: initial experience from Turkey.|pdf=|usr=010}}
| |
| − | {{tp|p=32557817|t=2020. B lines in COVID-19: "Unspecificity" is not "meaningless".|pdf=|usr=010}}
| |
| − | {{tp|p=32572392|t=2020. Eosinopenia as an early diagnostic marker of COVID-19 at the time of the epidemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32578687|t=2020. COVID-19 findings identified in chest computed tomography: a pictorial essay.|pdf=|usr=010}}
| |
| − | {{tp|p=32579876|t=2020. Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32543298|t=2020. Development of an automatic integrated gene detection system for novel Severe acute respiratory syndrome-related coronavirus (SARS-CoV 2).|pdf=|usr=010}}
| |
| − | {{tp|p=32572707|t=2020. The role of initial chest X-ray in triaging patients with suspected COVID-19 during the pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32586646|t=2020. Electrocardiographic features of patients with COVID-19 pneumonia.|pdf=|usr=010}}
| |
| − | {{tp|p=32562294|t=2020. Neurosonology during the COVID-19 pandemic (Editorial commentary from the chairs of the ultrasound panel of the EAN).|pdf=|usr=010}}
| |
| − | {{tp|p=32567006|t=2020. End-to-end automatic differentiation of the coronavirus disease 2019 (COVID-19) from viral pneumonia based on chest CT.|pdf=|usr=010}}
| |
| − | {{tp|p=32561970|t=2020. (18)F-Fluorocholine uptake matching CT lesions in the lungs of a patient clinically cured from COVID-19 syndrome.|pdf=|usr=010}}
| |
| − | {{tp|p=32556400|t=2020. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series.|pdf=|usr=010}}
| |
| − | {{tp|p=32591890|t=2020. Cohort study of chest CT and clinical changes in 29 patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=010}}
| |
| − | {{tp|p=32591888|t=2020. Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation.|pdf=|usr=010}}
| |
| − | {{tp|p=32592118|t=2020. Evaluation of novel coronavirus disease (COVID-19) using quantitative lung CT and clinical data: prediction of short-term outcome.|pdf=|usr=010}}
| |
| − | {{tp|p=32546849|t=2020. Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR.|pdf=|usr=010}}
| |
| − | {{tp|p=32570810|t=2020. Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler.|pdf=|usr=010}}
| |
| − | {{tp|p=32583171|t=2020. Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases.|pdf=|usr=010}}
| |
| − | {{tp|p=32553834|t=2020. Correlation between arterial blood gas test and CT volumetry in patients with SARS-CoV-2 in the emergency department.|pdf=|usr=010}}
| |
| − | {{tp|p=32575728|t=2020. Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs.|pdf=|usr=010}}
| |
| − | {{tp|p=32554983|t=2020. The Limited Sensitivity of Chest Computed Tomography Relative to Reverse Transcription Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Systematic Review on COVID-19 Diagnostics.|pdf=|usr=010}}
| |
| − | {{tp|p=32542735|t=2020. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32553841|t=2020. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32562192|t=2020. Multi-modality imaging of inflammation and ischemia for assessment of myocardial injury in Covid-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32568543|t=2020. Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32562109|t=2020. 2019 novel coronavirus (COVID-19) pneumonia complications: the importance of lung ultrasound.|pdf=|usr=010}}
| |
| − | {{tp|p=32554043|t=2020. Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections.|pdf=|usr=010}}
| |
| − | {{tp|p=32544099|t=2020. IL-6 combined with CD8+ T cell count early predict in-hospital mortality for patients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32588277|t=2020. Chest computed tomography findings of COVID-19 pneumonia: pictorial essay with literature review.|pdf=|usr=010}}
| |
| − | {{tp|p=32577869|t=2020. (18)F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces.|pdf=|usr=010}}
| |
| − | {{tp|p=32542458|t=2020. Appropriate terms for chest CT features in COVID-19 infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32563278|t=2020. Association between high serum total cortisol concentrations and mortality from COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32590775|t=2020. Chest CT of COVID-19 in patients with a negative first RT-PCR test: Comparison with patients with a positive first RT-PCR test.|pdf=|usr=010}}
| |
| − | {{tp|p=32555547|t=2020. Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?|pdf=|usr=010}}
| |
| − | {{tp|p=32556807|t=2020. Coronavirus disease 2019 (COVID-19) in children: a systematic review of imaging findings.|pdf=|usr=010}}
| |
| − | {{tp|p=32588200|t=2020. Truncated inception net: COVID-19 outbreak screening using chest X-rays.|pdf=|usr=010}}
| |
| − | {{tp|p=32589673|t=2020. New machine learning method for image-based diagnosis of COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32591286|t=2020. Reporting radiographers' interpretation and use of the British Society of Thoracic Imaging's coding system when reporting COVID-19 chest x-rays.|pdf=|usr=010}}
| |
| − | {{tp|p=32562280|t=2020. COVID-19 and ABO blood groups.|pdf=|usr=010}}
| |
| − | {{tp|p=32538694|t=2020. Coronavirus Disease (COVID-19) Detected at the Lung Apices During CT Angiography in Acute Stroke Assessment.|pdf=|usr=010}}
| |
| − | {{tp|p=32538693|t=2020. On the Role of Chest Radiography and CT in the Coronavirus Disease (COVID-19) Pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32583852|t=2020. Review of Current Advances in Serologic Testing for COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32577723|t=2020. Antibody Testing for COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32588812|t=2020. Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections.|pdf=|usr=010}}
| |
| − | {{tp|p=32573207|t=2020. Molecular diagnosis of COVID-19: Challenges and research needs.|pdf=|usr=010}}
| |
| − | {{tp|p=32568341|t=2020. Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus.|pdf=|usr=010}}
| |
| − | {{tp|p=32581086|t=2020. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32586931|t=2020. Testing strategy for SARS-CoV-2 in the paediatric emergency department.|pdf=|usr=010}}
| |
| − | {{tp|p=32586794|t=2020. Covid-19: Timing is critical for antibody tests, finds Cochrane review.|pdf=|usr=010}}
| |
| − | {{tp|p=32580937|t=2020. Covid-19 antibody tests: a briefing.|pdf=|usr=010}}
| |
| − | {{tp|p=32548635|t=2020. Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020.|pdf=|usr=010}}
| |
| − | {{tp|p=32544948|t=2020. Pool size selection when testing for SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32584464|t=2020. Antibody tests for identification of current and past infection with SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32568604|t=2020. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32571201|t=2020. PET and SPECT Imaging in the SARS-CoV-2 Pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32588938|t=2020. Serum Amyloid A protein has been undervalued as a biomarker in cases of COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32589600|t=2020. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=010}}
| |
| − | {{tp|p=32576313|t=2020. A Proposed COVID-19 Testing Algorithm.|pdf=|usr=010}}
| |
| − | {{tp|p=32574401|t=2020. Usefulness of lung ultrasound imaging in COVID-19 pneumonia: The persisting need of safety and evidences.|pdf=|usr=010}}
| |
| − | {{tp|p=32556199|t=2020. Global evaluation of echocardiography in patients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32584420|t=2020. LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins.|pdf=|usr=010}}
| |
| − | {{tp|p=32588660|t=2020. The role of chest computed tomography in the management of COVID-19: A review of results and recommendations.|pdf=|usr=010}}
| |
| − | {{tp|p=32543300|t=2020. Laboratory abnormalities related to prolonged hospitalization in COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32569358|t=2020. COVID-19 TestNorm - A tool to normalize COVID-19 testing names to LOINC codes.|pdf=|usr=010}}
| |
| − | {{tp|p=32589736|t=2020. What to expect from antibody assays of SARS-CoV-2?|pdf=|usr=010}}
| |
| − | {{tp|p=32573713|t=2020. Laboratory tests and outcome for patients with COVID-19: A systematic review and meta-analysis.|pdf=|usr=010}}
| |
| − | {{tp|p=32571894|t=2020. Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection.|pdf=|usr=010}}
| |
| − | {{tp|p=32554480|t=2020. When to re-test: An examination of repeat COVID PCR patterns in an ambulatory population.|pdf=|usr=010}}
| |
| − | {{tp|p=32562797|t=2020. SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics.|pdf=|usr=010}}
| |
| − | {{tp|p=32558485|t=2020. Genomewide Association Study of Severe Covid-19 with Respiratory Failure.|pdf=|usr=010}}
| |
| − | {{tp|p=32569495|t=2020. Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32578403|t=2020. Rare CT manifestions of an asymptomatic girl with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32562732|t=2020. Computed Tomography, Deep Learning and Ultrasonography Role in the Diagnosis of COVID-19 Pendemic Lung Infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32584166|t=2020. Spectrum of Imaging Findings on Chest Radiographs, US, CT, and MRI Images in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32570265|t=2020. Lung Ultrasound in COVID-19 Pneumonia: Correlations with Chest CT on Hospital admission.|pdf=|usr=010}}
| |
| − | {{tp|p=32554992|t=2020. Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana Covid-19 Patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32578378|t=2020. Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses.|pdf=|usr=010}}
| |
| − | {{tp|p=32584766|t=2020. [Radiological manifestation of COVID-19].|pdf=|usr=010}}
| |
| − | {{tp|p=32588412|t=2020. Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".|pdf=|usr=010}}
| |
| − | {{tp|p=32588411|t=2020. Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".|pdf=|usr=010}}
| |
| − | {{tp|p=32539257|t=2020. [Recommendations for treatment of severe coronavirus disease 2019 based on critical care ultrasound].|pdf=|usr=010}}
| |
